LLVK
LLVK is a selective inhibitor of IκB phosphorylation. It effectively reduces LPS-induced pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) . LLVK shows potential for research in inflammatory bowel disease and rheumatoid arthritis.
Product Specifications
Field of Research
Signal Transduction
Molecular Weight
471.63
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
